Business · 09/10/2019Updated: 10/17/2026 · 1 min read
FDA Awards Priority Review Voucher to Bavarian Nordic for JYNNEOS Smallpox and Monkeypox Vaccine
Summary
The FDA has issued a priority review voucher to Bavarian Nordic, the manufacturer of JYNNEOS, a vaccine for smallpox and monkeypox, following a review of its material threat medical countermeasure product application.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →